Mumbai, Maharashtra
GST No. 27AIUPK8634J1ZH
Call 07942822493 72% Response Rate
Send Enquiry
| Packaging Type | Vial |
| Form | Injection |
| Usage/Application | Personal |
| Compostion | sacituzumab govitecan-hziy |
| Storage Condition | 2-8 Degree Celsius |
| Prescription/Non prescription | Prescription |
TRODELVY® (sacituzumab govitecan-hziy) is a prescription medicine used to treat adults with:
It is not known if TRODELVY is safe and effective in people with moderate or severe liver problems or in children.
View Complete details
Minimum Order Quantity: 50 Piece
| Strength | 75iu |
| Dose | Menotrophin (75IU) |
| Packaging Type | Vial |
| Drug Strength | Menotrophin (75IU) |
| Product Type | Finished Product |
| Company | Bharat Serums & Vaccines Ltd |
| Composition | Menotrophin (75IU) |
| Country of Origin | Made in India |
View Complete details
Minimum Order Quantity: 10 Piece
Product Brochure
| Strength | 100 mg |
| Packaging Size | 5 ml |
| Packaging Type | Ampoule |
| Composition | Octreotide 100mg |
| Usage/Application | To treat severe diarrhea and acromegaly also VIP-omas |
Additional Information:
View Complete details
| Packaging Type | Box |
| Form | Injection |
| Usage/Application | Clinic |
| Compostion | (Dinutuximab beta 20mg/4.5ml) |
| Storage Condition | (2 DegreeC - 8 DegreeC). |
| Prescription/Non prescription | Prescription |
| Manufactured | EUSA Pharma |
View Complete details
| Packaging Type | Vial |
Tecvayli 153mg Injection contains the active substance Teclistamab. It is an anticancer medication classified as a bispecific monoclonal antibody.
Tecvayli Injection is used for the treatment of adult patients with relapsed or refractory multiple myeloma, a type of cancer affecting plasma cells in the bone marrow, who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 antibody.
Tecvayli works by targeting and binding to both B-cell maturation antigen (BCMA) on myeloma cells and CD3 on T cells. This dual binding activates T cells to recognise and destroy the BCMA-expressing myeloma cells.
Inform your doctor before starting treatment with Tecvayli 153mg Injection, as it may lead to serious side effects such as cytokine release syndrome (CRS), neurotoxicities, and infections. Regular monitoring and prompt management of these conditions are crucial during therapy.
Make sure to inform your physician of all the medicines you are taking before starting treatment with Tecvayli 153mg Injection. Report any symptoms such as difficulty breathing, cough, fever, chest pain, weakness, or seizures to your doctor.
Uses of Tecvayli 153mg InjectionTo treat adult patients with relapsed or refractory multiple myeloma (a type of cancer affecting plasma cells in the bone marrow) who have previously received at least four lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 antibody.
Therapeutic Effects of Tecvayli 153mg InjectionTecvayli 153mg Injection works by targeting and binding specifically to both B-cell maturation antigen (BCMA) on myeloma cells and CD3 on T cells. This dual binding activates T cells to recognise and destroy the BCMA-expressing myeloma cells, thereby inhibiting their growth and proliferation.
Interaction of Tecvayli 153mg Injection with other drugsInform your healthcare professional about all the medicines you take, including prescription medications, over-the-counter medications, nutritional and vitamin supplements, and herbal products.
Certain medications interacting with Tecvayli 153mg Injection may reduce effectiveness by causing undesirable side effects.
More Information about Tecvayli 153mg InjectionA healthcare professional administers Tecvayli 153mg Injection via intravenous infusion. The infusion is given over a specified duration as per your doctor’s treatment schedule. Do not self-administer the injection or alter the infusion schedule without consulting your healthcare provider.
View Complete details
| Form | Injection |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
View Complete details
Minimum Order Quantity: 10 Box of 10 Vials
Product Brochure
| Strength | 1.6 g |
| Quantity | 10 |
| Quantity Unit | Box |
| COMPOSITION | cefiderocol |
| COUNTRY OF ORIGIN | INDIA |
Fetroja® (cefiderocol) is indicated in patients 18 years of age or older for the treatment of complicated urinary tract infections (cUTIs), including pyelonephritis caused by the following susceptible Gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Enterobacter cloacae complex.
Fetroja is indicated in patients 18 years of age or older for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia, caused by the following susceptible Gram-negative microorganisms: Acinetobacter baumannii complex, Escherichia coli, Enterobacter cloacae complex, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Serratia marcescens.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Fetroja and other antibacterial drugs, Fetroja should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
View Complete details
Minimum Order Quantity: 10 Stripe
Product Brochure
| Strength | 50 mg |
| Packaging Size | 10*20 Tablets |
| Packaging Type | Box |
| Usage/Application | Hospital |
| Shelf Life | 36 months |
Additional Information:
View Complete details
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 1 MIU |
| Brand Name | Xylistin |
| Manufacturer | Cipla |
| Injection Site | IV or IM |
| Form | Solution |
| Packaging Type | Box |
Additional Information:
View Complete details
| Packaging size | 1.25 ml Vial |
| Strength | 20 mg/ml |
| Packaging Type | Vial |
| Prescription/Non prescription | Prescription |
| Manufacturer | AstraZeneca |
AstraZeneca’s Imjudo (tremelimumab) in combination with Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with unresectable hepatocellular carcinoma (HCC), the most common type of liver cancer. The novel dose and schedule of the combination, which includes a single dose of the anti-CTLA-4 antibody Imjudo 300mg added to the anti-PD-L1 antibody Imfinzi 1500mg followed by Imfinzi every four weeks, is called the STRIDE regimen (Single Tremelimumab Regular Interval Durvalumab).
The approval by the US Food and Drug Administration (FDA) was based on positive results from the HIMALAYA Phase III trial. In this trial, patients treated with the combination of Imjudo and Imfinzi experienced a 22% reduction in the risk of death versus sorafenib (based on a hazard ratio [HR] of 0.78, 95% confidence interval [CI] 0.66-0.92 p=0.0035).1 Results were also published in the New England Journal of Medicine Evidence showing that an estimated 31% of patients treated with the combination were still alive after three years, with 20% of patients treated with sorafenib still alive at the same duration of follow-up.2
Liver cancer is the third-leading cause of cancer death and the sixth most commonly diagnosed cancer worldwide.3,4 It is the fastest rising cause of cancer-related deaths in the US, with approximately 36,000 new diagnoses each year.5,6
View Complete details
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 25mg |
| Packaging Size | 0.5ml |
Additional Information:
View Complete details
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 2 MIU |
| Injection Site | IV or IM |
| Form | Powder |
| Packaging Type | Vial |
Additional Information:
View Complete details
Minimum Order Quantity: 10 Box
Product Brochure
| Pack Size | 10 Tablets |
| Country of Origin | Made in India |
Additional Information:
View Complete details
| Dosage/Strength | 50 mg |
| Brand | Phosome |
| Composition | LIPOSOMAL AMPHOTERICIN |
| Manufacturer | Cipla |
| Also Gives | PCD Pharma Franchise |
| Shelf life | 2 YRS |
| Country of Origin | Made in India |
View Complete details
| Strength | 20%/100 ml |
| Type | Infusion |
| Brand | Alburel (Reliance) |
| Usage/Application | Commercial |
| Shelf life | 2 YEAR |
| Company | Reliance Life Sciences |
| Composition | ALBUMIN |
| Storage | Store in a refrigerator (2 - 8 DegreeC). Do not freeze |
| Form | INFUSION |
| Manufactured By | Reliance Life Sciences |
| Medicine Type | INFUSION |
| Mfg Name | Reliance Life Sciences |
| Salt Name | ALBUMIN |
| Country of Origin | Made in India |
View Complete details
| Strength | 10 mg |
| Drug Name | Everolimus 10 mg |
| Generic Name | Everolimus 10 mg |
| Form | Tablet |
Afinitor 10mg Tablet must be taken in a dose and duration as per the prescription. It can be taken with or without food but make sure to take it at about the same time every day. An overdose of this medicine may have serious side effects on the body.
The common side effects of this medicine include infection, fever, cough, fatigue, diarrhea, and upper respiratory infection. If any of the side effects persist or bother you, consult the doctor immediately. Inform the doctor immediately if you experience any allergic reactions (rash, shortness of breath, coughing, swelling, etc.). Always seek medical advice if you have increased thirst or increased frequency of urination, suffer from shortness of breath, cough or fever, or need to receive any vaccination after taking this medication.
Before taking this medicine, it is important to consult your doctor if you have any ongoing medication for any underlying disease. Pregnant and breastfeeding women must inform the doctor prior to the initiation of this treatment. During the treatment, your doctor may advise you for some laboratory tests to know the effects of the medicine in the body. It may affect male or female fertility, so consult the doctor if you are planning to have a child.
View Complete details
| Drug Name | Everolimus Tab |
| Generic Name | Certican 0.75mg |
| Form | Tablet |
Certican 0.75mg Tablet must be taken in a dose and duration as per the prescription. It can be taken with or without food but make sure to take it at about the same time every day. An overdose of this medicine may have serious side effects on the body.
The common side effects of this medicine include infection, fever, cough, fatigue, diarrhea, and upper respiratory infection. If any of the side effects persist or bother you, consult the doctor immediately. Inform the doctor immediately if you experience any allergic reactions (rash, shortness of breath, coughing, swelling, etc.). Always seek medical advice if you have increased thirst or increased frequency of urination, suffer from shortness of breath, cough or fever, or need to receive any vaccination after taking this medication.
Before taking this medicine, it is important to consult your doctor if you have any ongoing medication for any underlying disease. Pregnant and breastfeeding women must inform the doctor prior to the initiation of this treatment. During the treatment, your doctor may advise you for some laboratory tests to know the effects of the medicine in the body. It may affect male or female fertility, so consult the doctor if you are planning to have a child.
View Complete details
| Strength | 500 mg |
| Packaging Type | Vial |
View Complete details
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 200 mg |
Additional Information:
View Complete details
Minimum Order Quantity: 10 Piece
Product Brochure
| Packaging Type | Box |
| Brand Name | zydus |
| Usage | Hospital |
| Shelf Life | 36 month |
View Complete details
| Strength | 150 mg/ml |
| Brand | Reliance Life Sciences |
| Prescription/Non prescription | Prescription |
View Complete details
| Packaging Size | 1 ml |
| Strength | 40 mg/ml |
| Brand | Abbott |
Kenacort 40mg Injection is generally administered by a doctor or a nurse. You should not self-administer this medicine at home. Get the injection regularly at the same time each day to get maximum benefits from it. It is important to keep using the medicine regularly until your doctor tells you it is safe to stop.
This medicine may cause a few side effects such as infection, headache, or injection site reaction. Talk to your doctor if you are worried about side effects or they do not go away. This medicine may make you more susceptible to viral infections, so you should stay away from people who have these infections. In general, you should try to avoid situations that make your symptoms worse (things like pollen and dust mites) and it is best not to smoke.
Before starting to use Kenacort 40mg Injection you should let your doctor know if you are pregnant or breastfeeding. If you use this medicine for a long time, your doctor may want to carry out certain medical tests to check your progress.
View Complete details
Minimum Order Quantity: 10 Piece
Product Brochure
| Motor Power | 5 HP |
| Prescription/Non prescription | Prescription |
| Voltage | 420 V |
| Power Consumption | 3 Kwh |
Additional Information:
View Complete details
| Manufacturer | GLENMART |
| Brand | DEGHOR- 80 |
| Packaging Size | 1X1 VIAL |
| Composition | Degarelix For Injection |
| Form | Injection |
| Deals in | PCD Pharma |
| Country of Origin | Made in India |
View Complete details
Minimum Order Quantity: 10 Bottle
Product Brochure
| Strength | 10 mg |
| Packaging Size | 30 Capsules |
| Manfacturer | NATCO |
| Country of Origin | Made in India |
Additional Information:
View Complete details
| Strength | 40 mcg |
| Packaging Type | Vial |
| Composition | Darbepoetin Alfa Inj |
| Brand Name | Cresp 40mg inj |
| Brand | Cresp 40mg inj |
| Manufacturer | Dr. Reddy's |
View Complete details
| Strength | 50 mg |
| Form | Injection |
| Packaging Type | Vial |
| Brand | Flubin 50mg |
| Storage Condition | 2 Celsius TO 8 Celsius |
| Prescription/Non prescription | Prescription |
| Usage | Hospital |
| Storage Conditions | 2 Celsius TO 8 Celsius |
View Complete details
| Strength | 10 mg |
| Packaging Size | 1 ml |
| Form | Injection |
View Complete details
Abcixirel 10mg Injection is administered under the supervision of a doctor. Your doctor will decide the dose and duration of the medicine for you. You should continue all your other medicines that are advised by the doctor for your long-term treatment even after this injection.
Use of this medicine may cause low blood platelets and increase your risk of bleeding. Let your doctor know immediately if you see pinpoint rash or blood in your vomits, urine, or stool. Your doctor will explain the benefits and risks associated with this medicine before it is administered.
This medicine is used with caution for some people. Thus, you must inform the doctor if you are suffering from any bleeding disorder, kidney or liver disease. Also, let your doctor know if you are pregnant or breastfeeding and about all the other medications that you are taking regularly.
View Complete details
| Dosage/Strength | 100 mg |
| Item Name | Venclyxto 100mg |
| Form | Tablet |
View Complete details